Home 9 Neurology 9 All Videos For Neurology 9 Boehringer Ingelheim: ESOC 2019 – How NOAC selection and reversal can help protect our patients: Your questions answered

Boehringer Ingelheim: ESOC 2019 – How NOAC selection and reversal can help protect our patients: Your questions answered

June 27, 2019

1) Keeping pace with advances in anticoagulation – Stephen Davis, Australia

 

2) What is the evidence for dabigatran? – Richard A. Bernstein, USA

 

3) What is the evidence for NOAC reversal strategies? – Sheila Martins, Brazil

 

4 How do we manage dabigatran and idarucizumab in neurological emergencies – Martin Grond, Germany

0 Comments

Newsletter

Keep up to date with our latest
articles and journals